# FDA 483 - Linde Inc - March 26, 2026

Source: https://www.keypedia.com/records/483/linde-inc/120137c1-539e-47a7-a89a-b4a67c3a98b8

> FDA 483 for Linde Inc on March 26, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Linde Inc
- Inspection Date: 2026-03-26
- Product Type: drugs
- Office Name: FDA District Office — Philadelphia, Pennsylvania
- Summary: An FDA inspection of Linde Inc, a medical gas manufacturer and distributor in Stockertown, PA, identified a significant quality control deficiency. The firm failed to establish a written testing program or conduct stability studies for its USP grade gases. This lapse resulted in the manufacturing and distribution of numerous product lots without proper stability assessment.

## Related Officers

- [Luxuly Abraham](https://www.keypedia.com/people/luxuly-abraham/d33e3164-ec89-488b-bab9-a9ec30544970)

Company: https://www.keypedia.com/companies/linde-inc/68486945-e8e2-4db4-82e2-f02915d2deb1

Office: https://www.keypedia.com/offices/fda-district-office-philadelphia-pennsylvania/e70a6e70-40b2-49e4-8360-c3db36c4d2a0